Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Hepatitis C reinfection rates up in direct-acting antiviral era
26 Feb 2022
There is an increased rate of hepatitis C virus (HCV) reinfection among people who inject drugs after the scale-up of direct-acting antivirals, reports a recent Scotland study.
Hepatitis C reinfection rates up in direct-acting antiviral era
26 Feb 2022STRIDE regimen boosts OS in unresectable HCC
25 Feb 2022
bởiRoshini Claire Anthony
The addition of tremelimumab to durvalumab (STRIDE regimen) in the first-line setting improved overall survival (OS) compared with sorafenib in patients with advanced unresectable hepatocellular carcinoma (HCC), according to results of the phase III HIMALAYA trial.